|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-0.99/-0.11
|
Enterprise Value
2.75M
|
Balance Sheet |
Book Value Per Share
-0.43
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
253.57K
|
Operating Revenue Per Share
0.02
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/05/21 03:31 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases. |